The immunogenicity of human and murine cytomegaloviruses (Q33970944)

30 July 2017

1 reference

title

The immunogenicity of human and murine cytomegaloviruses. (English)

1 reference

30 July 2017

Reddehase MJ

1

1 reference

30 July 2017

publication date

1 August 2000

1 reference

Current Opinion in Immunology

30 July 2017

published in

1 reference

30 July 2017

volume

12

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

390-396

1 reference

Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Immune evasion by cytomegalovirus--survival strategies of a highly adapted opportunist.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Morphological and cytochemical analysis of human cytomegalovirus inoculum: correlation of free particles in inoculum with counterparts in infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Multiplicity dependent expression of the predominant phosphoprotein pp65 of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

The cytolytic T lymphocyte response to the murine cytomegalovirus. II. Detection of virus replication stage-specific antigens by separate populations of in vivo active cytolytic T lymphocyte precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Studies on the morphogenesis of murine cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83).

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Implication of gammadelta T cells in the human immune response to cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Escape of human cytomegalovirus from HLA-DR-restricted CD4(+) T-cell response is mediated by repression of gamma interferon-induced class II transactivator expression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Cytomegalovirus evasion of natural killer cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Cytomegaloviral control of MHC class I function in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Late-phase expression of a murine cytomegalovirus immediate-early antigen recognized by cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

T-cell epitope mapping by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900106-0

7 January 2021

10.1016/S0952-7915(00)00106-0

Identifiers

DOI

1 reference

30 July 2017

1 reference